Title 42 — The Public Health and Welfare
Chapter 23 — Development and Control of Atomic Energy
§ 2142. Domestic medical isotope production
Statutory text
The Commission may issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if, in addition to any other requirement of this chapter—
the Commission determines that—
there is no alternative medical isotope production target that can be used in that reactor; and
the proposed recipient of the medical isotope production target has provided assurances that, whenever an alternative medical isotope production target can be used in that reactor, it will use that alternative in lieu of highly enriched uranium; and
the Secretary of Energy has certified that the United States Government is actively supporting the development of an alternative medical isotope production target that can be used in that reactor.
As used in this section—
the term “alternative medical isotope production target” means a nuclear reactor target which is enriched to less than 20 percent of the isotope U–235;
a target “can be used” in a nuclear research or test reactor if—
the target has been qualified by the Reduced Enrichment Research and Test Reactor Program of the Department of Energy; and
use of the target will permit the large majority of ongoing and planned experiments and medical isotope production to be conducted in the reactor without a large percentage increase in the total cost of operating the reactor;
the term “highly enriched uranium” means uranium enriched to 20 percent or more in the isotope U–235; and
the term “medical isotope” includes molybdenum-99, iodine-131, xenon-133, and other radioactive materials used to produce a radiopharmaceutical for diagnostic or therapeutic procedures or for research and development.
Legislative history
Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.
American Medical Isotopes Production Act of 2012
Pub. L. 112–239 div. C title XXXI § 3176(a) · 126 Stat. 1632
Enacted · 42 U.S.C. § 2142
Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a), Jan. 2, 2013, 126 Stat. 2215
Source evidence
Code source credit
Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a), Jan. 2, 2013, 126 Stat. 2215Enacted provision · exact public law section
(a) In General.— Chapter 10 of the Atomic Energy Act of 1954 (42 U.S.C. 2131 et seq.) is amended by adding at the end the following: “a. 42 USC 2142. The Commission may issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if, in addition to any other requirement of this Act— “(1) the Commission determines that— “(A) there is no alternative medical isotope production target that can be used in that reactor; and “(B) the proposed recipient of the medical isotope production target has provided assurances that, whenever an alternative medical isotope production target can be used in that reactor, it will use that alternative in lieu of highly enriched uranium; and “(2) the Secretary of Energy has certified that the United States Government is actively supporting the development of an alternative medical isotope production target that can be used in that reactor. “b. Definitions. As used in this section— “(1) the term ‘alternative medical isotope production target’ means a nuclear reactor target which is enriched to less than 20 percent of the isotope U–235; “(2) a target ‘can be used’ in a nuclear research or test reactor if— “(A) the target has been qualified by the Reduced Enrichment Research and Test Reactor Program of the Department of Energy; and “(B) use of the target will permit the large majority of ongoing and planned experiments and medical isotope production to be conducted in the reactor without a large percentage increase in the total cost of operating the reactor; “(3) the term ‘highly enriched uranium’ means uranium enriched to 20 percent or more in the isotope U–235; and “(4) the term ‘medical isotope’ includes molybdenum-99, iodine-131, xenon-133, and other radioactive materials used to produce a radiopharmaceutical for diagnostic or therapeutic procedures or for research and development.” .National Defense Authorization Act for Fiscal Year 2014
Pub. L. 113–66 div. C title XXXI § 3144 · 127 Stat. 672
Inserted · 42 U.S.C. § 2142
Pub. L. 113–66 inserted section designation and catchline
Source evidence
Code amendment note
Pub. L. 113–66 inserted section designation and catchline.Enacted provision · exact public law section
SEC. 3144. TECHNICAL AMENDMENT TO ATOMIC ENERGY ACT OF 1954. Chapter 10 of the Atomic Energy Act of 1954 (42 U.S.C. 2131 et seq.), as amended by section 3176 of the National Defense Authorization Act for Fiscal Year 2013 (Public Law 112–239; 126 Stat. 2215), 42 USC 2142. is amended in the matter following section 111 by inserting before “a. The Commission” the following: “Sec. 112. Domestic Medical Isotope Production.—”.
2 of 2 references resolved to an enrolled provision
Editorial Notes
References in Text
This chapter, referred to in subsec. (a), was in the original “this Act”, meaning act Aug. 1, 1946, ch. 724, as added by act Aug. 30, 1954, ch. 1073, § 1, 68 Stat. 919, known as the Atomic Energy Act of 1954, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 2011 of this title and Tables.
Amendments
2013—Pub. L. 113–66 inserted section designation and catchline.
Credits
1946–2013 · 2 acts
- 1946Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a), , 126 Stat. 2215
- 2013Pub. L. 113–66, div. C, title XXXI, § 3144, , 127 Stat. 1071.
Show as published
(Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a), , 126 Stat. 2215; Pub. L. 113–66, div. C, title XXXI, § 3144, , 127 Stat. 1071.)